UroGen Pharma Ltd.

NASDAQ:URGN

Biotechnology

Healthcare
$29.79 -1.22%

-$0.40 today

Market cap
$1.46B
Beta
1.62
P/E (TTM)
-12.2
EPS (TTM)
-$2.65
52W Low $12.73High $33.79

Volume 1.14M

Average 0.79M

Price history

UroGen Pharma Ltd. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+17.89%

Period high

$50.29

Period low

$17.00

Latest

$29.79

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13G/ANov 13, 2026Nov 13, 2026
10-QNov 4, 2026Nov 4, 2026
8-KNov 4, 2026Nov 4, 2026
S-8Nov 4, 2026Nov 4, 2026
SC 13G/AOct 27, 2026Oct 27, 2026
4Oct 9, 2026Oct 9, 2026
4Sep 9, 2026Sep 9, 2026
4Sep 9, 2026Sep 9, 2026
4Aug 28, 2026Aug 28, 2026
4Aug 24, 2026Aug 24, 2026
8-KAug 20, 2026Aug 20, 2026
SC 13G/AAug 12, 2026Aug 12, 2026
8-KAug 5, 2026Aug 5, 2026
10-QAug 5, 2026Aug 5, 2026
4Jul 10, 2026Jul 10, 2026

Competitors

Who does UroGen Pharma Ltd. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about URGN's filings, answered from its disclosures.

What is the latest URGN filing?

The latest filing shown is SC 13G/A dated Nov 13, 2026.

How many recent filings does URGN have?

Intrinsic Alpha currently shows 20 recent filings for URGN.